Jean-Luc Monin
Research Subjects
Jean-Luc Monin has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Mehran Monchi
Department of Intensive Care Medicine , General Hospital of Melun , Melun , France
3 shared publicationsCatherine Adams
Department of Cardiology , General Hospital , Argenteuil , France
2 shared publicationsChristophe Chauvel
Department of Cardiology , Clinique Saint-Augustin , Bordeaux , France
2 shared publicationsChristophe Tribouilloy
Department of Cardiology , University Hospital , Amiens, France
2 shared publicationsDamien Metz
Department of Cardiology , University Hospital , Reims , France
2 shared publicationsHélène Petit-Eisenmann
Department of Cardiac Surgery , University Hospital , Strasbourg , France
2 shared publications
Latest Publications
- Open Access
- 18 February 2014
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 16 (6) , 639-647
Prevalence and Clinical Impact of QRS Duration in Patients with Low-Flow/Low-Gradient Aortic Stenosis Due to Left Ventricular Systolic Dysfunction
Aims To evaluate the prognostic impact of QRS width in patients with low-flow/low-gradient aortic stenosis (LF/LGAS). Methods and results Among 88 consecutive patients referred to our institution for LF/LGAS from September 1994 to March 2007, baseline demographic, clinical, echocardiographic, and electrocardiographic data were collected. This population was divided into two groups according to baseline QRS duration (cut-off QRS ≥130 ms). Follow-up data, including electrocardiographic evolution and overall mortality, were analysed. The mean follow-up duration was 3.1 (2.2–6.2) years. In the whole group, 67 patients underwent surgical aortic valve replacement. Forty-nine patients (56%) had a QRS duration ≥130 ms. Among operated patients, there was no significant change in QRS duration between baseline and latest follow-up (126 ± 26 ms vs. 131 ± 25 ms; P = 0.82). In addition, wider QRS was a strong independent predictor of overall mortality (hazard ratio 2.20, 95% confidence interval 1.15–4.24; P = 0.027). Conclusion Significant intraventricular conduction disturbances are common in patients with LF/LGAS and do not recover after aortic valve replacement. QRS duration is strongly associated with mortality in this selected population.
- 18 February 2014
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 16 (6) , 639-647
Open AccessPrevalence and Clinical Impact of QRS Duration in Patients with Low-Flow/Low-Gradient Aortic Stenosis Due to Left Ventricular Systolic Dysfunction
Aims To evaluate the prognostic impact of QRS width in patients with low-flow/low-gradient aortic stenosis (LF/LGAS). Methods and results Among 88 consecutive patients referred to our institution for LF/LGAS from September 1994 to March 2007, baseline demographic, clinical, echocardiographic, and electrocardiographic data were collected. This population was divided into two groups according to baseline QRS duration (cut-off QRS ≥130 ms). Follow-up data, including electrocardiographic evolution and overall mortality, were analysed. The mean follow-up duration was 3.1 (2.2–6.2) years. In the whole group, 67 patients underwent surgical aortic valve replacement. Forty-nine patients (56%) had a QRS duration ≥130 ms. Among operated patients, there was no significant change in QRS duration between baseline and latest follow-up (126 ± 26 ms vs. 131 ± 25 ms; P = 0.82). In addition, wider QRS was a strong independent predictor of overall mortality (hazard ratio 2.20, 95% confidence interval 1.15–4.24; P = 0.027). Conclusion Significant intraventricular conduction disturbances are common in patients with LF/LGAS and do not recover after aortic valve replacement. QRS duration is strongly associated with mortality in this selected population.
- Open Access
- 24 June 2012
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 33 (19) , 2426-2433
Outcomes of pseudo-severe aortic stenosis under conservative treatment
In the setting of low-flow/low-gradient aortic stenosis (LF/LGAS), outcomes of pseudo-severe aortic stenosis (AS) remain poorly described. This study was aimed to assess the outcome of patients with pseudo-severe AS under conservative treatment. Among 305 patients from the European Registry of LF/LGAS, the outcomes of the 107 patients followed under conservative treatment were analysed. Based on the results of dobutamine echocardiography, patients were divided into group IA [left ventricular (LV) contractile reserve present with true-severe AS, n = 43], group IB [pseudo-severe AS (n = 29) defined as LV contractile reserve with a final aortic valve area ≥1.2 cm2 and a mean transaortic pressure gradient n = 35). The rate of death within 5 years was significantly lower in the group IB (43 ± 11%, n = 10), when compared with the group IA (91 ± 6%, n = 33; P = 0.001) and the group II (100%, n = 23; P < 0.001). The Cox proportional hazard model analysis demonstrated that the hazard ratio for death in the group IB remained significantly lower than in the other groups, even after adjustment for currently established risk factors. Furthermore, the 5-year survival of pseudo-severe AS patients was comparable with that of propensity-matched patients with systolic heart failure and no evidence of valve disease. In patients with pseudo-severe AS, the 5-year survival under conservative treatment is better than in true-severe AS and comparable with that of propensity-matched patients with LV systolic dysfunction and no evidence of valve disease. Further studies are needed to define optimal therapeutic management in these patients.
- 24 June 2012
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 33 (19) , 2426-2433
Open AccessOutcomes of pseudo-severe aortic stenosis under conservative treatment
In the setting of low-flow/low-gradient aortic stenosis (LF/LGAS), outcomes of pseudo-severe aortic stenosis (AS) remain poorly described. This study was aimed to assess the outcome of patients with pseudo-severe AS under conservative treatment. Among 305 patients from the European Registry of LF/LGAS, the outcomes of the 107 patients followed under conservative treatment were analysed. Based on the results of dobutamine echocardiography, patients were divided into group IA [left ventricular (LV) contractile reserve present with true-severe AS, n = 43], group IB [pseudo-severe AS (n = 29) defined as LV contractile reserve with a final aortic valve area ≥1.2 cm2 and a mean transaortic pressure gradient n = 35). The rate of death within 5 years was significantly lower in the group IB (43 ± 11%, n = 10), when compared with the group IA (91 ± 6%, n = 33; P = 0.001) and the group II (100%, n = 23; P < 0.001). The Cox proportional hazard model analysis demonstrated that the hazard ratio for death in the group IB remained significantly lower than in the other groups, even after adjustment for currently established risk factors. Furthermore, the 5-year survival of pseudo-severe AS patients was comparable with that of propensity-matched patients with systolic heart failure and no evidence of valve disease. In patients with pseudo-severe AS, the 5-year survival under conservative treatment is better than in true-severe AS and comparable with that of propensity-matched patients with LV systolic dysfunction and no evidence of valve disease. Further studies are needed to define optimal therapeutic management in these patients.
- 20 November 2009
- Vol. 59 (9) , 1283-4
[Aortic stenosis].
- 7 July 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (1) , 69-75
Risk Score for Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
Background— The management of patients with asymptomatic severe aortic stenosis remains controversial. We sought to develop a continuous risk score for predicting the midterm development of symptoms or adverse events in this setting. Methods and Results— We prospectively followed 107 patients with asymptomatic aortic stenosis (aged 72 years [63 to 77]; 35 women; aortic-jet velocity, 4.1 m/s [3.5 to 4.4]) at a single center in France. Predefined end points for assessing outcome were the occurrence within 24 months of death or aortic valve replacement necessitated by symptoms or by a positive exercise test. Variables independently associated with outcome were used to build a score that was validated in an independent cohort of 107 patients from Belgium. Independent predictors of outcome were female sex, peak aortic-jet velocity, and B-type natriuretic peptide at baseline. Accordingly, the score could be calculated as follows: Score=[peak velocity (m/s)×2]+(natural logarithm of B-type natriuretic peptide×1.5)+1.5 (if female sex). Event-free survival after 20 months was 80% for patients within the first score quartile compared with only 7% for the fourth quartile. Areas under the receiver operating characteristic curve for the score were 0.90 and 0.89 in the development and validation cohorts, respectively. Conclusions— If further validation is achieved, this score may be useful to predict outcome in individual patients with asymptomatic aortic stenosis to select those who might benefit from early surgery.
- 7 July 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (1) , 69-75
Risk Score for Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
Background— The management of patients with asymptomatic severe aortic stenosis remains controversial. We sought to develop a continuous risk score for predicting the midterm development of symptoms or adverse events in this setting. Methods and Results— We prospectively followed 107 patients with asymptomatic aortic stenosis (aged 72 years [63 to 77]; 35 women; aortic-jet velocity, 4.1 m/s [3.5 to 4.4]) at a single center in France. Predefined end points for assessing outcome were the occurrence within 24 months of death or aortic valve replacement necessitated by symptoms or by a positive exercise test. Variables independently associated with outcome were used to build a score that was validated in an independent cohort of 107 patients from Belgium. Independent predictors of outcome were female sex, peak aortic-jet velocity, and B-type natriuretic peptide at baseline. Accordingly, the score could be calculated as follows: Score=[peak velocity (m/s)×2]+(natural logarithm of B-type natriuretic peptide×1.5)+1.5 (if female sex). Event-free survival after 20 months was 80% for patients within the first score quartile compared with only 7% for the fourth quartile. Areas under the receiver operating characteristic curve for the score were 0.90 and 0.89 in the development and validation cohorts, respectively. Conclusions— If further validation is achieved, this score may be useful to predict outcome in individual patients with asymptomatic aortic stenosis to select those who might benefit from early surgery.
Prosthesis–patient mismatch: myth or reality?
In most studies, prosthesis–patient mismatch is defined according to the projected EOA taken from published in vivo reference values for each type and size of prosthetic valves and indexed to the patient’s body surface area.2–5 9–13 A currently accepted definition is the following: no PPM if the projected …
Prosthesis–patient mismatch: myth or reality?
In most studies, prosthesis–patient mismatch is defined according to the projected EOA taken from published in vivo reference values for each type and size of prosthetic valves and indexed to the patient’s body surface area.2–5 9–13 A currently accepted definition is the following: no PPM if the projected …
- Open Access
- 27 September 2007
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 28 (21) , 2620-2626
Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival
To assess the prognostic impact of prosthesis-patient mismatch (PPM) in a large consecutive series of patients operated for low-gradient aortic stenosis (AS). Outcomes after surgery for low-gradient AS were prospectively assessed in 152 consecutive patients from seven institutions. There were 113 men (74%); mean age was 72 years (64–76); valve area, 0.7 cm2 (0.6–0.8); left ventricular (LV) ejection fraction 0.31 (0.25–0.37) and baseline mean transaortic pressure gradient (MPG), 30 mmHg (25–35) Among 139 patients with available prosthetic valve effective orifice area (EOA), PPM (defined by an indexed EOA ≤ 0.85 cm2/m2) was present in 79 patients (57%) and had no significant impact on post-operative mortality. Independent predictors of overall mortality were LV contractile reserve [hazard ratio (HR) 0.52; 95% confidence interval (CI) 0.35–0.78; P = 0.002], associated coronary artery bypass grafting (HR 1.87; 95% CI 1.24–2.82; P =0.003), baseline MPG (per 1 mmHg decrease to 10 mmHg; HR 1.03; 95% CI 1.01–1.06; P = 0.021), previous cancer (HR 2.13; 95% CI 1.05–4.29; P = 0.037), and logistic EuroSCORE (per 1% increase; HR 1.02; 95% CI 1.01–1.04; P = 0.040). In this large multicentre series of patients with low-gradient AS, we found that PPM (moderate in most cases) had no influence on post-operative mortality. Therefore, the performance of more complex interventions in order to avoid moderate PPM may not be justified in the setting of low-gradient AS, because their higher risk probably outweighs the expected benefit.
- 27 September 2007
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 28 (21) , 2620-2626
Open AccessLow-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival
To assess the prognostic impact of prosthesis-patient mismatch (PPM) in a large consecutive series of patients operated for low-gradient aortic stenosis (AS). Outcomes after surgery for low-gradient AS were prospectively assessed in 152 consecutive patients from seven institutions. There were 113 men (74%); mean age was 72 years (64–76); valve area, 0.7 cm2 (0.6–0.8); left ventricular (LV) ejection fraction 0.31 (0.25–0.37) and baseline mean transaortic pressure gradient (MPG), 30 mmHg (25–35) Among 139 patients with available prosthetic valve effective orifice area (EOA), PPM (defined by an indexed EOA ≤ 0.85 cm2/m2) was present in 79 patients (57%) and had no significant impact on post-operative mortality. Independent predictors of overall mortality were LV contractile reserve [hazard ratio (HR) 0.52; 95% confidence interval (CI) 0.35–0.78; P = 0.002], associated coronary artery bypass grafting (HR 1.87; 95% CI 1.24–2.82; P =0.003), baseline MPG (per 1 mmHg decrease to 10 mmHg; HR 1.03; 95% CI 1.01–1.06; P = 0.021), previous cancer (HR 2.13; 95% CI 1.05–4.29; P = 0.037), and logistic EuroSCORE (per 1% increase; HR 1.02; 95% CI 1.01–1.04; P = 0.040). In this large multicentre series of patients with low-gradient AS, we found that PPM (moderate in most cases) had no influence on post-operative mortality. Therefore, the performance of more complex interventions in order to avoid moderate PPM may not be justified in the setting of low-gradient AS, because their higher risk probably outweighs the expected benefit.